Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)
Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)
Active, not recruiting · NCT05607810 · Registry updated 2025-04-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT) | Diabetes Complications, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, blindness (disorder), cardiovascular disorder, diabetes mellitus, diabetic macular edema, diabetic peripheral angiopathy, diabetic retinopathy, endocrine system disorder, eye disorder, nervous system disorder, retinal disorder, vascular disorder, vision disorder | Active, not recruiting | Not stated | 2025-04-22 | NCT05607810 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Adverum Biotechnologies, Inc. | 6 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||